Newark, New Castle, USA, June 09, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global rapid infuser market was conducted by Growth Plus Reports in 2022 and is valued at US$ 1.02 billion ...

The global rapid infuser market, valued at $796.9 million in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $1,109 million by 2031, as per a recent report ...

The global rapid infuser market share analysis is poised to achieve USD 1,209.4 million in sales by 2025, fueled by increasing trauma cases, a surge in emergency surgeries, and the growing demand for ...

Durham-based 410 Medical has received up to nearly $2 million in U.S. military funding to develop two new versions of LifeFlow, its medical device for treating life-threatening low blood pressure ...

New devices address infusion delivery variability and expand the ICU Medical IV Performance Platform. Unlike traditional pumps that rely on specific setups and conditions for accurate delivery ...

Rapid is also zooming ahead in a new trial of the TigerTriever 13 device. The Distals study will track the system’s ability to remove clots from isolated, harder-to-reach regions of the brain.

Rapid Medical receives FDA clearance at SNIS for TIGERTRIEVER 13, the smallest and only adjustable thrombectomy device for ischemic stroke treatment ...

About Rapid Medical Kaneka Corporation, headquartered in Tokyo, Japan, has exclusive distribution rights with Rapid Medical in the country. Rapid Medical expands what’s possible in neurovascular ...

Market Segmentation: Based on product, the global rapid infuser market is segmented into hand-held devices and trolley-mounted devices.

New devices address infusion delivery variability and expand the ICU Medical IV Performance Platform.